Core Scientific (CORZ) Change in Accured Expenses (2020 - 2026)

Core Scientific has disclosed Change in Accured Expenses across 7 years of filings, most recently posting $171.6 million for Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 151.87% year-over-year to $171.6 million; the TTM figure through Jun 2026 stood at $67.0 million (down 43.7% YoY), while the FY2025 annual figure was -$17.4 million, down 1025.53% from the prior year.
• Change in Accured Expenses came in at $171.6 million for Q2 2026 at Core Scientific, up from -$16.4 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $171.6 million in Q2 2026 to a low of -$45.9 million in Q3 2025.
• Average Change in Accured Expenses over 5 years is $16.0 million, with a median of $2.0 million recorded in 2024.
• Year-over-year, Change in Accured Expenses surged 1755.99% in 2022 and tumbled 3415.53% in 2025.
• Over 5 years, Change in Accured Expenses stood at $17.5 million in 2022, then jumped by 571.9% to $117.4 million in 2023, then slumped by 60.17% to $46.8 million in 2024, then sank by 190.56% to -$42.3 million in 2025, then jumped by 505.21% to $171.6 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $171.6 million in Q2 2026, -$16.4 million in Q1 2026, and -$42.3 million in Q4 2025.